← Eichor
Study identifier: NCT06014931 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Condition: Post-intensive Care Syndrome  ·  Sponsor: Vanderbilt University

PhaseNA
Planned participants202
Who can joinAll sexes, 45 Years to no upper limit
Healthy volunteersNo

About this study

Intact cognitive skills are necessary for independent living, going to work, and managing finances, and any loss of cognitive skills places a burden on society akin to what is seen with Alzheimer's Disease and Related Dementias. The TelePORT Study (Telehealth-Enhanced Patient-Oriented Recovery Trajectories after Intensive Care) is the first post-intensive care syndrome longitudinal long-term cognitive impairment intervention study. The societal effect from long-term cognitive impairment after critical illness is great as many of these patients are employable adults or functional retirees.

This description comes directly from the study's public registry record.

Talk to the study team

Leanne M Boehm, PhD  ·  615-343-1051  ·  leanne.boehm@vanderbilt.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Ohio State University Wexner Medical CenterColumbus, Ohio, United StatesNot Yet Recruiting
Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06014931